Access Bio Signs Supply Contract for COVID-19 Diagnostic Kits Worth 77 Billion KRW
[Asia Economy Reporter Minji Lee] Access Bio announced on the 25th that it has signed a supply contract for COVID-19 antigen test kits with Intrivo Diagnostics, a medical device distribution company. The contract amount is 76.944 billion KRW, which is 178% of the sales revenue as of the end of 2019.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
